https://repository.auw.edu.bd/handle/123456789/832 Tue, 09 Jun 2026 23:30:53 GMT 2026-06-09T23:30:53Z https://repository.auw.edu.bd/handle/123456789/1051 MicroRNA in Fibrotic Disorders: A Potential Target for Future Therapeutics Mollah, AKM Moinul Haque Fibrotic disorders are defined by accumulating excessive extracellular matrix (ECM) components, especially collagens, in various organs, leading to tissue scarring and organ dysfunction. These conditions are associated with significant challenges in the healthcare system because of their progressive nature and limited treatment options. MicroRNAs (miRNAs) are small non-coding RNA molecules (ap- proximately 22 nucleotides) that modulate gene expression by selectively targeting mRNAs for degradation or translational repression. MiRNAs have recently been identified as potential targets for therapeutic developments in fibrotic disorders. They play vital roles in inducing fibrotic phenotype by regulating fibroblast activation and ECM remodeling. Multiple strategies for targeting specific miRNAs in fibrotic disorders have been explored, including antisense oligonucleotides, small molecule modulators, and natural compounds. This review discussed the role of miRNAs in different fibrotic disorders, including cardiac fibrosis, liver fibrosis, kidney fibrosis, lung fibrosis, dermal fibrosis, and primary myelofibrosis, with recent advances in developing miRNA-based therapeutics. Sun, 01 Jan 2023 00:00:00 GMT https://repository.auw.edu.bd/handle/123456789/1051 2023-01-01T00:00:00Z https://repository.auw.edu.bd/handle/123456789/1050 Exploring Inflammasome Complex as a Therapeutic Approach in Inflammatory Diseases Mollah, AKM Moinul Haque Inflammasomes, a group of multiprotein complexes, are essential in regulating inflam- mation and immune responses. Several inflammasomes, including nucleotide-binding domain leucine-rich repeat-containing protein 1 (NLRP1), NLRP3, NLRP6, NLRP7, NLRP12, interferon- inducible protein 16 (IFI16), NOD-like receptor family CARD domain-containing protein 4 (NLRC4), absent in melanoma 2 (AIM2), and pyrin, have been studied in various inflammatory diseases. Activating inflammasomes leads to the processing and production of proinflammatory cytokines, such as interleukin (IL)-1β and IL-18. The NLRP3 inflammasome is the most extensively studied and well characterized. Consequently, targeting inflammasomes (particularly NLRP3) with several compounds, including small molecule inhibitors and natural compounds, has been studied as a potential therapeutic strategy. This review provides a comprehensive overview of different inflam- masomes and their roles in six inflammatory diseases, including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, atherosclerosis, type 2 diabetes, and obesity. We also discussed different strategies that target inflammasomes to develop effective therapeutics. Sun, 01 Jan 2023 00:00:00 GMT https://repository.auw.edu.bd/handle/123456789/1050 2023-01-01T00:00:00Z